Month: November 2026

Muscle and joint pain can interfere with exercise, employment, sleep and everyday independence. Although treatment depends on the underlying cause, topical preparations offer a convenient way to manage local discomfort. Fisiocrem is a brand of externally applied products promoted for musculoskeletal symptoms. Its best-known formulation, fisiocrem Solugel, combines botanical extracts with menthol. It may provide useful short-term relief for some people, but its benefits should be considered alongside the limitations of the evidence. Importantly, reducing pain does not necessarily mean that an injured muscle, tendon or joint has healed.

Ingredients and proposed actions

The Solugel formulation contains extracts of Arnica montana, Calendula officinalis and Hypericum perforatum, together with Melaleuca alternifolia oil and menthol. Arnica has traditionally been used for bruising and muscular discomfort. Calendula, commonly called pot marigold, has a history of use in skin preparations, while hypericum is better known as St John’s wort. Melaleuca, or tea tree oil, has antimicrobial properties. However, traditional use and laboratory findings do not automatically establish clinically important pain relief when these substances are combined and applied over deeper musculoskeletal tissues.

Menthol provides a clearer explanation for the immediate cooling sensation. It activates cold-sensitive receptors, particularly TRPM8, and can modify the perception of pain. This sensory effect may make an uncomfortable area feel more comfortable without changing its structural condition. Gentle rubbing during application may also provide temporary relief through touch, relaxation and altered sensory input. Consequently, the overall experience can reflect the formulation, the massage and the person’s expectations. It is difficult to determine how much each botanical ingredient contributes without trials comparing the components separately.

Evidence of effectiveness

A product-specific randomised, double-blind, placebo-controlled trial published in 2022 enrolled 200 adults with acute or chronic musculoskeletal pain. Participants were allocated to fisiocrem or a similar cream without active ingredients, applied twice daily for fourteen days. The researchers reported greater reductions in pain and perceived stiffness with fisiocrem, with differences detectable thirty minutes after application. Participants receiving the active preparation also reported better recovery perceptions during follow-up. These findings support the possibility of symptomatic benefit beyond that provided by applying and massaging a placebo cream.

Nevertheless, this study does not settle every question about effectiveness. It was funded by fisiocrem, lasted only two weeks and included several different diagnoses, including tendinopathy, sprains, spinal pain and symptomatic osteoarthritis. Such diversity makes condition-specific conclusions difficult. Menthol’s distinctive sensation may also complicate blinding, even when preparations look similar. Furthermore, measured joint mobility did not differ significantly between groups. Independent replication, longer follow-up and comparisons with established treatments would strengthen confidence. Improvements in reported pain or recovery should not be interpreted as proof of accelerated tissue repair or lasting disease modification.

Evidence concerning individual ingredients must also be interpreted cautiously. A Cochrane review found that one trial of a particular arnica gel suggested similar symptom benefits to topical ibuprofen in hand osteoarthritis. However, this cannot establish that fisiocrem works equally well, because extraction methods, concentrations and accompanying ingredients differ. More broadly, topical nonsteroidal anti-inflammatory drugs, such as diclofenac, have a larger evidence base for certain musculoskeletal conditions. Fisiocrem therefore represents an optional symptomatic treatment rather than an evidence-equivalent replacement for every established therapy.

Practical clinical use

For muscle pain, fisiocrem may be considered for localised aches after unfamiliar exercise, mild muscular strains or tension-related discomfort. Its non-greasy formulation and easy application may encourage use, particularly among people who prefer topical treatments. Nevertheless, exercise-related soreness usually improves naturally, making personal impressions of effectiveness difficult to separate from normal recovery. Persistent or recurrent symptoms require attention to training load, strength, movement habits and recovery. Pain relief should support appropriate activity, not encourage someone to continue exercising through an injury that is becoming progressively worse.

For joint pain, expectations should be similarly realistic. A topical preparation may ease discomfort around a painful joint, but it cannot rebuild damaged cartilage, correct instability or control systemic inflammatory arthritis. Exercise therapy, education and condition-specific management remain important. The brand also markets a separate Joint Ease formulation containing additional ingredients, including boswellia and black seed oil. Products bearing the same brand name are not interchangeable: evidence concerning Solugel should not automatically be applied to other formulations. Users should check exactly which product they have and its intended indications.

A practical approach is to judge benefit by function as well as pain scores. For example, does application make walking, prescribed exercises or ordinary household tasks more comfortable? If there is no worthwhile improvement, continued use adds cost without clear value. Even when helpful, the cream should accompany gradual strengthening and appropriate load modification. People taking other medicines or managing several health conditions can ask a pharmacist whether a topical herbal preparation is a sensible individual choice.

Application and safety

The Australian Solugel directions advise applying a few grams to the affected area three to four times daily as required. Users should follow their own pack’s instructions, since formulations and recommendations may vary between countries. Apply only to intact skin, avoid the eyes and mucous membranes, and wash the hands afterwards unless treating them. Gentle application is preferable to forceful massage over a recently injured area. Avoid combining topical pain products on the same site or using heating pads or tight coverings unless a healthcare professional confirms this is appropriate.

“Natural” does not mean free from adverse effects. Arnica, calendula, tea tree oil and other constituents can cause irritation or allergic contact dermatitis. People with allergies to plants in the daisy family should be particularly cautious about arnica and calendula. Stop using the product if redness, itching, blistering or worsening discomfort develops. Seek advice before use during pregnancy, breastfeeding or in children. People with fragile skin, impaired sensation or diabetes-related neuropathy should also obtain guidance. Fisiocrem must never be swallowed or applied to open wounds.

Overall, fisiocrem may offer temporary relief of muscle and joint discomfort, with some supportive clinical evidence but important uncertainties. It is best used as an adjunct to diagnosis, rehabilitation and sensible activity management, rather than as a cure. Severe pain, inability to bear weight, fever or a hot, swollen joint warrants prompt assessment.

Formthotics are prefabricated, heat-mouldable foot orthoses designed to fit inside footwear and modify the interaction between the foot, shoe and ground. Used by podiatrists and other health professionals, they offer an adaptable alternative to both simple cushioning insoles and individually manufactured orthoses. Their value lies principally in improving comfort, redistributing pressure and altering loads on painful tissues. However, they should not be regarded as a universal correction for abnormal foot posture. Successful treatment depends on accurate diagnosis, fitting and integration with other measures, including exercise and suitable footwear.

The devices are manufactured from a proprietary closed-cell polyethylene foam called Formax. Different models offer varying densities, thicknesses and combinations of cushioning and support. Unlike a rigid plastic orthosis, the foam is flexible and can be heated and moulded to accommodate the foot within the shoe. Clinicians can further adapt the device using wedges, pads or local modifications. Although this process individualises the fit, it does not make Formthotics equivalent to an orthosis manufactured from an individual cast or scan. They remain prefabricated devices that are adjusted to meet needs.

Their effects are best understood through load management rather than the simplistic idea of placing every foot into an ideal alignment. Increasing contact beneath the arch can redistribute plantar pressure, while cushioning may reduce discomfort at sensitive areas. Changes in the forces acting beneath the foot can also influence the demands placed on muscles, tendons and joints. The response varies between individuals and depends on footwear and activity. Pronation is a normal component of walking and running; its presence alone does not establish a problem or justify prescribing an orthosis.

One indication is plantar heel pain, often called plantar fasciitis. Formthotics may help some patients tolerate standing and walking by changing plantar loading and supporting the arch. Nevertheless, relief is neither immediate nor guaranteed. A randomised trial by Landorf and colleagues found that prefabricated and customised orthoses produced small short-term functional benefits compared with sham devices, without advantages at twelve months. The 2023 plantar fasciitis guideline recommends against using orthoses as an isolated treatment. They are more appropriately combined with plantar fascia and calf stretching, strengthening, education and activity adjustment.

Formthotics may also be considered for painful flexible flat feet when symptoms are associated with prolonged standing, walking or sporting activity. The aim is to improve comfort and functional tolerance, not permanently reconstruct the arch. In adults with progressive arch collapse or posterior tibial tendon dysfunction, a simple insert may provide insufficient support, and bracing or specialist management may be required. Similarly, painless flexible flat feet in children usually do not require treatment merely because their arches appear low. Prescribing should be driven by symptoms and clinical findings rather than appearance alone.

Forefoot pain provides another potential application. In selected cases of metatarsalgia, modifications such as a correctly positioned metatarsal pad can redistribute loading away from painful metatarsal heads. Footwear must provide sufficient width and depth, because an insert placed in a tight shoe can increase compression and worsen symptoms. Conditions such as interdigital nerve irritation, joint inflammation and stress injury require different management despite producing similar pain. Formthotics may complement treatment, but persistent focal pain should prompt reassessment rather than repeated insole adjustments without a clear diagnosis of the underlying cause.

For runners and other active people, these orthoses can sometimes reduce symptoms sufficiently to support rehabilitation. However, evidence for foot orthoses in general should not automatically be interpreted as proof that this particular brand prevents injuries or outperforms alternatives. Neither comfort during an initial fitting nor a visible change in foot posture establishes lasting clinical benefit. Training errors, inadequate recovery, muscle capacity and footwear remain important considerations. An orthosis should support a progressive return to activity, rather than allow an athlete to continue overloading an injured structure without appropriate rehabilitation.

Clinical assessment should consider pain location, symptom behaviour, skin condition, joint mobility, strength, gait and the shoes in which the orthoses will be worn. Selection of foam density and device shape should reflect the treatment objective, available shoe space and patient preference. Heat moulding and additional modifications should follow the manufacturer’s instructions. A gradual introduction is often sensible, with wear time increased according to comfort. Review should assess meaningful outcomes such as walking tolerance and pain during daily activities, rather than assuming that a more visibly supported arch represents success.

Safety is particularly important in people with diabetes, peripheral neuropathy, poor circulation or previous ulceration. These patients may not detect excessive pressure or rubbing, so professional assessment and careful skin monitoring are essential. Standard Formthotics are not automatically suitable for treating an active ulcer or replacing specialised offloading devices. New blisters, persistent redness, numbness or increasing pain warrant stopping use and obtaining advice. The devices also need periodic inspection: compressed foam, wear and changes in footwear or symptoms may require modification or replacement. Their useful lifespan varies with loading and use.

Overall, Formthotics offer a practical, accessible means of individualising prefabricated foot orthoses. Their adjustability and cushioning make them useful for selected painful foot conditions, particularly when a comfortable device can facilitate movement and rehabilitation. Their limitations are equally important: they do not correct every biomechanical variation, guarantee injury prevention or replace a diagnosis. The strongest clinical approach is therefore selective and outcome-focused, combining an appropriately fitted orthosis with education, footwear advice, exercise and review. Used this way, Formthotics are a valuable component of care rather than a standalone cure.